Suppr超能文献

口服减敏治疗对屋尘螨过敏的疗效(作者译)

[Efficacy of oral hyposensitization treatment in house dust mite allergy (author's transl)].

作者信息

Urbanek R, Gehl R

出版信息

Monatsschr Kinderheilkd. 1982 Mar;130(3):150-2.

PMID:7087973
Abstract

32 children with perennial asthma and/or rhinitis due to house dust mite (HDM) allergy have been hyposensitized orally for a period of 42 weeks. The sensitization against HDM was confirmed by skin testing, RAST determinations and nasal provocation tests before and after treatment. The trial was double-blind, with 17 patients receiving the HDM extract and 15 receiving placebo. Patients returned for assessment at 6, 18, 30, and 42 weeks, nasal airways resistance testing, lung function tests (FVC), FEV1, PEF) and clinical evaluations were performed. The results of the subjective and objective assessments failed to demonstrate any superiority of oral hyposensitization with house dust mite extract compared to placebo.

摘要

32名因屋尘螨(HDM)过敏而患有常年性哮喘和/或鼻炎的儿童接受了为期42周的口服减敏治疗。治疗前后通过皮肤试验、放射性变应原吸附试验(RAST)测定和鼻激发试验确认了对HDM的致敏情况。该试验为双盲试验,17名患者接受HDM提取物,15名患者接受安慰剂。患者在第6、18、30和42周返回进行评估,进行鼻气道阻力测试、肺功能测试(用力肺活量(FVC)、第一秒用力呼气容积(FEV1)、呼气峰值流量(PEF))和临床评估。主观和客观评估结果未能证明与安慰剂相比,口服屋尘螨提取物进行减敏治疗具有任何优势。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验